• Journal of Nutrition and Health
• /
• 제36권10호
• /
• pp.1022-1029
• /
• 2003

This study was undertaken to evaluate the antitumor activities of Cordyceps militaris of silkworm pupa (CMP) and silkworm larva (CML), as compared with the effect of cordycepin, an active compound found in Cordyceps militaris. Antiproliferation effect of the test materials were evaluated in the sarcoma-180 cells using the MTT test. For the in vivo study, ICR mice were inoculated i.p. with 1.0 ${\times}$ 10$^{6}$ sarcoma-180 cells/mouse on Day 0, and were again i.p. injected with one of the following substances from Day 1 to Day 10 : saline (control group), 50 mg/kg (CMP50, CML50) ,100 ma/kg (CMP100, CML100), or 200 mg/kg (CMP200, CML200) of Cordyceps militaris water extracts, or 1 mg/kg (C1), 2 mg/kg (C2), or 4 mg/kg (C4) of cordycepin. Pretreatment of the sarcoma-180 cells with 100 mg/ml, 500 mg/ml, and 1000 mg/ml of CML (60.1$\pm$2.5％, 49.8$\pm$3.7％, and 45.4$\pm$0.1％ of the value for untreated control cells, respectively) or CMP (68.3$\pm$2.1％, 55.1$\pm$0.9％, and 51.4$\pm$3.5％ of the value for control cells, respectively) for 48 hrs significantly decreased the survival rate (proliferation) of tumor cells (p<0.05). Body weight of the control mice bearing ascites tumor and injected with saline was 1.4 times of the value for normal animals at day 18. Mice bearing ascites tumor and injected with cordycepin (1, 2, or 4 mg/kg) exhibited a significantly lighter body weight compared with the control mice, while animals injected with CMP or CML (50, 100, or 200 mg/kg) showed a significantly lighter body weight compared with the mice injected with cordycepin. Mice injected with CMP50, CMP100, or CMP200 mg/kg (or CML50, CML100, or CML200 mg/kg) showed a 133％ (or 90％), 80％ (or 62％), and 68％ (or 52％) longer mean survival time, and those treated with C1, C2, or C4 exhibited a 54％, 91％ and 80％ longer survival time compared to the value for control mice injected with saline. These results indicate that the hot-water extracts of Cordyceps militaris of both silkworm pupa and silkworm larva have an anti-proliferation effect of tumor cells as well as the life prolongation effect in mice bearing ascites tumor, which are superior to the activities of cordycepin.

• ETRI Journal
• /
• 제37권3호
• /
• pp.584-594
• /
• 2015

To date, many different kinds of logic styles for hardware countermeasures have been developed; for example, SABL, TDPL, and DyCML. Current mode-based logic styles are useful as they consume less power compared to voltage mode-based logic styles such as SABL and TDPL. Although we developed TPDyCML in 2012 and presented it at the WISA 2012 conference, we have further optimized it in this paper using a binary decision diagram algorithm and confirmed its properties through a practical implementation of the AES S-box. In this paper, we will explain the outcome of HSPICE simulations, which included correlation power attacks, on AES S-boxes configured using a compact NMOS tree constructed from either SABL, CMOS, TDPL, DyCML, or TPDyCML. In addition, to compare the performance of each logic style in greater detail, we will carry out a mutual information analysis (MIA). Our results confirm that our logic style has good properties as a hardware countermeasure and 15% less information leakage than those secure logic styles used in our MIA.

• 항공우주의학회지
• /
• 제31권3호
• /
• pp.82-83
• /
• 2021

Chronic myeloid leukemia (CML) is myeloproliferative neoplasm associated with a characteristic chromosomal translocation (bcr-abl) called Philadelphia chromosome which plays a key role in the pathogenesis. Approximately 85% of patients with CML are in the chronic phase at the time of diagnosis. During this phase, patients are well tolerated and have few symptoms. But untreated, over the course of several years progresses to an accelerated phase and ultimately to a blast crisis, the terminal phase. CML is largely treated with targeted drug therapy called tyrosine-kinase inhibitors (TKIs) which have led to dramatically improved long-term survival rates since 2001. These drugs became standard treatment of this disease and allow most patients to have much better quality of life when compared to the former chemotherapy drugs and the bone marrow transplantation. Imatinib (Gleevec or Glivec, Norvatis) was the first of these TKIs and found to inhibit the progression of CML in the majority of patients (65%-75%) sufficiently to achieve remission. Since the advent of imatinib, CML has become the first neoplasm in which a medical treatment can give to the patient a normal life expectancy.

• 환경생물
• /
• 제39권4호
• /
• pp.559-572
• /
• 2021

가을 한국 남해 서부 해역의 수괴분석 및 식물플랑크톤 군집의 공간분포 특성을 이해하기 위해 2021년 9월 15개 정점의 표층과 엽록소 a 최댓층(CML)을 대상으로 조사하였다. 결과, 수괴는 고온, 저염의 연안수(CW), 고온, 고염의 쓰시마난류(TWC) 및 이 두 수괴의 혼합특성을 보이는 혼합수(MW)로 구분되었다. 용존산소 포화도는 표층에서는 95% 이상을 보이지만, CML 일부 해역은 낮은 불포화 상태를 보였고, 탁도는 표층과 저층 모두에서 농도가 높았다. 엽록소 a 농도는 표층이 0.90±0.43 ㎍ L^-1 변동 폭으로 연안수에서 1.1 ㎍ L^-1 이상, 혼합수에서 1.0 ㎍ L^-1 전후, 그리고 쓰시마난류에서 0.5 ㎍ L^-1 이하를 나타내었다. CML은 1.64±0.54 ㎍ L^-1 변동 폭으로 표층보다 약 2배 높았다. 식물플랑크톤 종 조성은 31속 57종으로 규조류가 57.8%, 와편모조류가 35.1%, 규질편모조류 5.3%, 그리고 은편모조류가 1.8%로 단조로웠다. 현존량은 표층이 4.6±7.6 cells mL^-1 변동 폭으로 연안에서 30 cells mL^-1 이상, 혼합수에서 2~5 cells mL^-1, 그리고 쓰시마난류에서 2 cells mL^-1 이하를 나타내었다. CML은 5.7±8.4 cells mL^-1 변동 폭으로 표층보다 다소 높았다. 5% 이상 우점율을 보이는 우점종은 표층에서 Rhizosolenia flagilissima f. flagilissima, Skeletonema costatum-ls, Nitzschia sp./small size가 각 8.4%, 6.1%, 5.2% 순이었고, CML은 Rh. flagilisima f. flagilissima가 12.0%의 우점율을 나타내었으나, 낮은 현존량으로 우점종에 대한 의미 부여가 어려웠다. 다양도 지수는 표층이 2.36±0.40 변동 폭으로 쓰시마난류에서 높고, 혼합수에서 낮았고, CML은 2.29±0.52 변동 폭으로 표층보다 다소 낮았다. 우점도 지수는 표층이 0.50±0.15 변동 폭으로 혼합수에서 0.5 이상, 쓰시마난류에서 0.5 이하로 다양도와 다른 특성을 보였다. 상관분석 및 주성분 분석 결과는 식물플랑크톤 현존량은 연안수 및 혼합수에서 높고, 높은 탁도를 보인 일부 혼합수 및 쓰시마난류에서 낮은 것에서, 각수괴의 확장 및 혼합 정도에 따라 식물플랑크톤 군집의 출현 및 분포에 커다란 영향을 미치는 것으로 판단되었다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
• /
• pp.273.1-273.1
• /
• 2003

The CML -Ex is a traditional oriental medicine. The main constituents of CML-Ex are Rehmanniae Radix, Achyranthis Radix and Eucommiae Cortex. The objective of this study was to investigate the anti-inflammatory and analgesic activities of CML -Ex under various acute and chronic inflammatory and analgesic models. The drug was orally administered at 30, 100, 300 and 600 mg/kg body weight. (omitted)

• Molecules and Cells
• /
• 제39권12호
• /
• pp.869-876
• /
• 2016

Cantharidin (CTD) is an active compound isolated from the traditional Chinese medicine blister beetle and displayed anticancer properties against various types of cancer cells. However, little is known about its effect on human chronic myeloid leukemia (CML) cells, including imatinib-resistant CML cells. The objective of this study was to investigate whether CTD could overcome imatinib resistance in imatinib-resistant CML cells and to explore the possible underlying mechanisms associated with the effect. Our results showed that CTD strongly inhibited the growth of both imatinib-sensitive and imatinib-resistant CML cells. CTD induced cell cycle arrest at mitotic phase and triggered DNA damage in CML cells. The ATM/ATR inhibitor CGK733 abrogated CTD-induced mitotic arrest but promoted the cytotoxic effects of CTD. In addition, we demonstrated that CTD downregulated the expression of the BCR-ABL protein and suppressed its downstream signal transduction. Real-time quantitative PCR revealed that CTD inhibited BCR-ABL at transcriptional level. Knockdown of BCR-ABL increased the cell-killing effects of CTD in K562 cells. These findings indicated that CTD overcomes imatinib resistance through depletion of BCR-ABL. Taken together, CTD is an important new candidate agent for CML therapy.

• Transactions on Electrical and Electronic Materials
• /
• 제18권4호
• /
• pp.185-189
• /
• 2017

This paper proposes a low power frequency divider for an integrated CMOS phase-locked loop (PLL). An injection-locked frequency divider (ILFD) was designed, along with a current-mode logic (CML) frequency divider in order to obtain a broadband and high-frequency operation. A ring oscillator was designed to operate at 1.2 GHz, and the ILFD was used to divide the frequency of its input signal by two. The structure of the ILFD is similar to that of the ring oscillator in order to ensure the frequency alignment between the oscillator and the ILFD. The CML frequency divider was used as the second stage of the divider. The proposed frequency divider was applied in a conventional PLL design, using a 0.18 ${\mu}m$ CMOS process. Simulation shows that the proposed divide-by-two ILFD and the divide-by-eight CML frequency dividers operated as expected for an input frequency of 1.2 GHz, with a power consumption of 30 mW.

• Molecules and Cells
• /
• 제44권7호
• /
• pp.444-457
• /
• 2021

Although the mechanism of chronic myeloid leukemia (CML) initiation through BCR/ABL oncogene has been well characterized, CML cell differentiation into erythroid lineage cells remains poorly understood. Using CRISPR-Cas9 screening, we identify Chromobox 8 (CBX8) as a negative regulator of K562 cell differentiation into erythrocytes. CBX8 is degraded via proteasomal pathway during K562 cell differentiation, which activates the expression of erythroid differentiation-related genes that are repressed by CBX8 in the complex of PRC1. During the differentiation process, the serine/threonine-protein kinase PIM1 phosphorylates serine 196 on CBX8, which contributes to CBX8 reduction. When CD235A expression levels are analyzed, the result reveals that the knockdown of PIM1 inhibits K562 cell differentiation. We also identify TRIM28 as another interaction partner of CBX8 by proteomic analysis. Intriguingly, TRIM28 maintains protein stability of CBX8 and TRIM28 loss significantly induces proteasomal degradation of CBX8, resulting in an acceleration of erythroid differentiation. Here, we demonstrate the involvement of the CBX8-TRIM28 axis during CML cell differentiation, suggesting that CBX8 and TRIM28 are promising novel targets for CML research.

• 한국전자파학회논문지
• /
• 제20권10호
• /
• pp.1107-1113
• /
• 2009

본 논문에서는 K-Band에서 동작하는 1/2 주파수 분배기를 130 nm CMOS 공정을 이용하여 설계하고 제작한 결과를 보인다. 피드백 방식의 밀러 주파수 분배기는 20~25 GHz에서 동작하며 바이어스 전압 1.2 V에서 7.2 mW의 전력을 소모하고 코어 회로의 레이아웃 크기는 $315{\times}246\;um^2$이다. 밀러 주파수 분배기의 출력 신호를 2분 주시키기 위한 CML(Current Mode Logic) 주파수 분배기는 8.5~13 GHz에서 동작하며 5.7 mW의 전력을 소모하고, 코어 회로의 레이아웃 크기는 $91{\times}98\;um^2$이다. 또한 두 주파수 분배기를 결합하여 20~25 GHz의 입력 신호가 4분주되어 출력됨을 확인하였다.

• BMB Reports
• /
• 제29권3호
• /
• pp.241-247
• /
• 1996

The Philadelphia (Ph) chromosome is the single most intensively studied chromosome alteration characterizing a human malignancy. The specific genetic alteration of chronic myelogenous leukemia (CML) is the formation of the BCR/abl fusion gene in leukemic cells. The presence of the BCR/abl gene has important diagnostic and prognostic implications in CML. The detection of BCR/abl transcripts by reverse transcriptase based polymerase chain reaction (RT-PCR) was investigated in patients with CML in whom the Ph chromosome abnormality was documented by cytogenetic analysis. In a total of 68 CML patient cases, the Ph chromosome was found in 53 cases (77.9%) by cytogenetic analysis. On the other hand, sixty two cases (91.2%) were detected to have BCR/abl gene rearrangement Of these, b3a2 was 44 cases (64.7%) and b2a2 was 17 cases (25,0%). There was one case with both b3a2 and b2a2 (1.5%). Of the fifteen cases of Ph chromosome negative by cytogenetic anlaysis, the BCR/abl gene was observed in nine cases, The results of BCR/abl fusion gene confirmed by the direct sequencing method correlated well with PCR analysis, The amplified PCR products were detected by $1{\times}10^{-5}$ dilutions. In conclusion, PCR technique is sensitive, rapid and relatively simple for a laboratory test in detecting the BCR/abl fusion gene with CML regardless of the result of cytogenetic analysis.